Wakanaga Pharmaceutical Breaks Ground For California Factory
This article was originally published in PharmAsia News
Executive Summary
Osaka-based Wakanaga Pharmaceutical started construction of new factory in California, according to the company's U.S. subsidiary Wakanaga of America. Located in Riverside County, east of Los Angeles, the 5,000 square meter factory will start manufacturing more than 100 over-the-counter drugs early next year. Wakanaga invested ¥1.5 billion for the site and plans to complete the construction by the end of the year. The company will employ 100 people and distribute the products to North American markets including Canada and Mexico. (Click here for more - Japanese language
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.